Study: FDA Should Increase Social Media Use to Issue Safety Information

Drug Industry Daily
A A
A new CDER-funded study says the FDA is not taking full advantage of social media to communicate drug safety information — and should, for example, be making more use of Twitter in its campaigns.

To View This Article:

Login

Subscribe To Drug Industry Daily